# Atara Biotherapeutics, Inc.: Form 8-K, filed Apr 4, 2025

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2025-04-04
- Accepted by EDGAR: Apr 4, 2025, 16:10 ET
- Period: 2025-03-31
- Accession: 0000950170-25-051121
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000095017025051121/atra-20250331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000095017025051121/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000095017025051121/atra-20250331.htm

Filed Apr 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-051121. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.